FDA Working Group Considering Changes To OTC Cough/Cold Monograph

An FDA working group conducting a review of OTC cough and cold medicines for 2- to 11-year-old children will make recommendations this spring on actions the agency should take concerning use of the products for that age group, Office of Nonprescription Products officials said Jan. 17